TOPICAL RAPAMYCIN THERAPY TO ALLEVIATE CUTANEOUS MANIFESTATIONS OF TUBEROUS SCLEROSIS COMPLEX

$3,563,700FY2011Department of DefenseDOD

University Of Texas Health Science Center At Houston

Investigators